• Profile

Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy

International Urology and Nephrology Sep 14, 2017

Cai W, et al. - The significance of pretreatment prognostic nutritional index (PNI) was determined in patients with metastatic renal cell carcinoma (mRCC) with sorafenib or sunitinib as first-line targeted therapy. Findings suggested that low pretreatment PNI could be a significant risk factor for mRCC patients who received tyrosine kinase inhibitors as first-line target therapy. In addition, it would also increase the accuracy of the established prognostic model.


  • The Kaplan–Meier method was used to estimate the progression-free survival (PFS) and overall survival (OS) of 178 mRCC patients who received first-line therapy of sorafenib or sunitinib.
  • The log-rank test was applied to compare the survival outcomes of patients with low pretreatment PNI (PNI < 51.62) and high pretreatment PNI (PNI  ≥ 51.62), and Cox proportional hazard regression model was used to compare PFS and OS between these two groups. 
  • With the aid of Harrell concordance index, prognostic accuracy was evaluated.


  • The overall median PFS and OS time for all 178 patients were 11 months (95% CI 9–12 months) and 24 months (95% CI 19–33 months), respectively. 
  • Findings disclosed that patients with low pretreatment PNI both had significantly shorter median PFS (7 vs 19 months, P < 0.001) and OS (14 vs 50 months, P < 0.001) than those with high PNI.
  • Multivariate analysis displayed that pretreatment PNI was an independent predictor of OS (HR 1.658, 95% CI 1.040–2.614, P = 0.033) and an independent predictor of PFS as well (HR 1.842, 95% CI 1.226–2.766, P = 0.003).
  • The model built by the addition of pretreatment PNI improved predictive accuracy of PFS and OS compared with the International Metastatic Renal Cell Carcinoma Database Consortium Model (Heng model) (c-index: 0.68 and 0.70).
  • PNI might be a preciser factor to predict PFS and OS (0.71 and 0.73), as compared to NLR (neutrophil-to-lymphocyte ratio) (0.69 and 0.72).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen